PLx Pharma Winddown Corp. Research and Development in Process
PLx Pharma Winddown Corp. reported Research and Development in Process of $272.50 thousand for the 50-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2014-05-12
- 2014-03-31: Research and Development in Process 50 month $272.50K.
| Period end | Research and Development in Process 50 month |
|---|---|
| 2014-03-31 | $272.50K 10-Q · filed 2014-05-12 |